Caprock Group, Inc. Dynavax Technologies Corp Transaction History

Caprock Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	BUY	$10.27 - $13.29 $277 - $358	27 Added 0.08%	33,277 $0
Q2 2022 Jul 26, 2022	BUY	$7.45 - $12.83 $61,462 - $105,847	8,250 Added 33.0%	33,250 $419,000
Q4 2021 Jan 18, 2022	BUY	$13.17 - $20.94 $171,210 - $272,220	13,000 Added 108.33%	25,000 $352,000
Q3 2021 Oct 07, 2021	BUY	$9.16 - $19.83 $109,920 - $237,959	12,000 New	12,000 $231,000

288

131M

507K

374K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.74B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.